Literature DB >> 23958003

Rate of transmission: a major determinant of the cost of clinical mastitis.

P M Down1, M J Green, C D Hudson.   

Abstract

The aim of this research was to use probabilistic sensitivity analysis to evaluate the relative importance of different components of a model designed to estimate the cost of clinical mastitis (CM). A particular focus was placed on the importance of pathogen transmission relative to other factors, such as milk price or treatment costs. A stochastic Monte Carlo model was developed to simulate a case of CM at the cow level and to calculate the associated costs for 5 defined treatment protocols. The 5 treatment protocols modeled were 3 d of antibiotic intramammary treatment, 5 d of antibiotic intramammary treatment, 3 d of intramammary and systemic antibiotic treatment, 3d of intramammary and systemic antibiotic treatment plus 1 d of nonsteroidal antiinflammatory drug treatment, and 5 d of intramammary and systemic antibiotic treatment. Uniform distributions were used throughout the model to enable investigation of the cost of CM over a spectrum of clinically realistic scenarios without specifying which scenario was more or less likely. A risk of transmission parameter distribution, based on literature values, was included to model the effect of pathogen transmission to uninfected cows, from cows that remained subclinically infected after treatment for CM. Spearman rank correlation coefficients were used to evaluate the relationships between model input values and the estimated cost of CM. Linear regression models were used to explore the effect that changes to specific independent variables had on the cost of CM. Risk of transmission was found to have the strongest association with the cost of CM, followed by bacteriological cure rate, cost of culling, and yield loss. Other factors such as milk price, cost of labor, and cost of medicines were of minimal influence in comparison. The cost of CM was similar for all 5 treatment protocols. The results from this study suggest that, when seeking to minimize the economic impact of CM in dairy herds, great emphasis should be placed on the reduction of pathogen transmission from cows with CM to uninfected cows.
Copyright © 2013 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mastitis; probabilistic sensitivity analysis; transmission; treatment

Mesh:

Substances:

Year:  2013        PMID: 23958003     DOI: 10.3168/jds.2012-6470

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  9 in total

1.  Financial and economic analyses of the impact of cattle mastitis on the profitability of Egyptian dairy farms.

Authors:  M F Azooz; Safaa A El-Wakeel; H M Yousef
Journal:  Vet World       Date:  2020-09-02

2.  Prediction of Streptococcus uberis clinical mastitis risk using Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) in dairy herds.

Authors:  Simon C Archer; Andrew J Bradley; Selin Cooper; Peers L Davies; Martin J Green
Journal:  Prev Vet Med       Date:  2017-05-17       Impact factor: 2.670

3.  Chitosan and cloxacillin combination improve antibiotic efficacy against different lifestyle of coagulase-negative Staphylococcus isolates from chronic bovine mastitis.

Authors:  María L Breser; Verónica Felipe; Luciana P Bohl; María S Orellano; Paula Isaac; Agustín Conesa; Virginia E Rivero; Silvia G Correa; Ismael D Bianco; Carina Porporatto
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

4.  An Observational Study Investigating Potential Risk Factors and Economic Impact for Bovine Ischaemic Teat Necrosis on Dairy Farms in Great Britain.

Authors:  Hayley E Crosby-Durrani; Roger W Blowey; Al Manning; João Sucena Afonso; Stuart D Carter; Nicholas J Evans; Joseph W Angell
Journal:  Front Vet Sci       Date:  2022-03-22

5.  Virulence and antimicrobial resistance gene profiles of Staphylococcus aureus associated with clinical mastitis in cattle.

Authors:  V K Jain; Mahavir Singh; Vinay G Joshi; Rajesh Chhabra; Kuldeep Singh; Y S Rana
Journal:  PLoS One       Date:  2022-05-03       Impact factor: 3.752

6.  Mastitis Pathogens with High Virulence in a Mouse Model Produce a Distinct Cytokine Profile In Vivo.

Authors:  Carl-Fredrik Johnzon; Karin Artursson; Robert Söderlund; Bengt Guss; Elin Rönnberg; Gunnar Pejler
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

7.  Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows.

Authors:  P M Down; A J Bradley; J E Breen; M J Green
Journal:  Prev Vet Med       Date:  2017-07-10       Impact factor: 2.670

8.  Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows.

Authors:  Vinícius da Silva Duarte; Roberto Sousa Dias; Andrew M Kropinski; Stefano Campanaro; Laura Treu; Carolina Siqueira; Marcella Silva Vieira; Isabela da Silva Paes; Gabriele Rocha Santana; Franciele Martins; Josicelli Souza Crispim; André da Silva Xavier; Camila Geovana Ferro; Pedro M P Vidigal; Cynthia Canêdo da Silva; Sérgio Oliveira de Paula
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

9.  Acute phase protein expressions in secretory and cistern lining epithelium tissues of the dairy cattle mammary gland during chronic mastitis caused by staphylococci.

Authors:  M Zalewska; E Kawecka-Grochocka; D Słoniewska; E Kościuczuk; S Marczak; W Jarmuż; L Zwierzchowski; E Bagnicka
Journal:  BMC Vet Res       Date:  2020-08-31       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.